ORTHODONTIX, INC./ F.W. MORT GUILFORD SC 13D

Company

Protalix BioTherapeutics, Inc.

Filed

May 5, 1998

Accession Number

0000950144-98-005573

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →